Skip to content

King Pharmaceuticals KG General Liability — Year 8

Other product segments

European Hospital Liability
5%
Commercial Auto Liability
2.3%
All other lines
0.1%
International
-0.1%

Similar metrics at other companies

CNA Financial logo
CNAGeneral Liability — Year 8
5.4%-0.3pp
Old Republic International logo
ORIGeneral Liability — Year 8
4.9%+0.5pp
The Hartford Financial Services Group logo
HIGGeneral Liability — 8th Year
7.8%+1.9pp
CNA Financial logo
CNAGeneral Liability — Year 9
5.4%+2.2pp
CNA Financial logo
CNAGeneral Liability — Year 7
8.4%+1.3pp
CNA Financial logo
CNAGeneral Liability — Year 1
3.4%0.0pp

Other financials

Income statement

See full
Revenue$10.2M+1,112%
Net income-$7.4M-1,786%
EPS (diluted)-$0.96-586%

Balance sheet

See full
Cash & equivalents$62.2M+1,724%
Total debt$176.7M
Total equity$121.4M+2,773%
Total assets$964.2M

Cash flow

See full
Operating cash flow-$15.1M-1,628%

Valuation

See full
Market cap$70.42M-67.6%
Enterprise value$184.93M-50.0%
P/E1.2×
P/S1.6×-24.3×

Profitability

See full
Net margin131.5%

Returns & leverage

See full
Return on equity90.8%
Debt / equity1.5×

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearEight.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's general liability — year 8.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is King Pharmaceuticals's general liability — year 8?
King Pharmaceuticals (KG) reported general liability — year 8 of 6.4% in Q4 2025.
What does general liability — year 8 mean?
Represents the total revenue or financial activity generated by the General Liability insurance segment during the eighth year of the reporting period. It reflects the company's ability to maintain and grow its liability insurance book amidst evolving market conditions.